OWKIN

Owkin is a company operating in the New York artificial intelligence scene, categorized within biotech-AI[1]. The company focuses on building what it describes as the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation while reshaping how humanity understands and engineers biology[2]. According to the company's positioning, it represents a shift from narrow AI tools toward true reasoning systems that autonomously advance discovery rather than merely assisting scientists[2]. Owkin operates in the technology, information and internet sector[3] and employs 427 people[3].

Something wrong or missing? Send a correction. Fixed within 24 hours.